CGBio
Scope
Date
~
-
Bio & Pharma
CGBio gets FDA approval for Novosis Putty
South Korea's bio-regenerative medical firm CGBio announced on Tuesday that its Novosis Putty has been designated as a breakthrough device by the US...
Jan 02, 2024 (Gmt+09:00)
-
Bio & Pharma
S.Korea's CGBio gets FDA approval for spinal implant
CGBio, a South Korean bio-regenerative medical company, announced on Monday that its "Advanced LumFix spinal fixation system," an implant and surgic...
Aug 14, 2023 (Gmt+09:00)
-
Beauty & Cosmetics
S.Korea's CGBio exports $8 mn filler to Australia, New Zealand
CGBio, a South Korean bio-regenerative medical company, announced on Thursday that it has signed a contract to export its hyaluronic acid (HA) fille...
Mar 24, 2023 (Gmt+09:00)
-
Bio & Pharma
CGBio inks export deal for hyaluronic acid fillers with Chinese distributor
CGBio, a South Korean bio-regenerative medical company, has signed an export deal with Shanghai Feiting Trading Co., a Chinese medical device distri...
Mar 22, 2023 (Gmt+09:00)
-
Beauty & Cosmetics
CGBio opens cosmetic surgery clinic in Bali using bio-medical tech
CGBio, a South Korean bio-renewable medical company, announced on Monday that it opened a medical esthetic clinic, called Nulook, in Bali, Indonesia...
Mar 14, 2023 (Gmt+09:00)